← Back to Search

My Diabetes Care for Diabetes

N/A
Waitlist Available
Led By William Martinez, MD, MS
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Type 2 Diabetes Mellitus
Age 18-75 years old
Must not have
Receiving dialysis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (t0), three-month follow-up (t1), six-month follow-up (t2), twelve-month follow-up (t3)
Awards & highlights

Summary

This trial will test if the My Diabetes Care portal can help improve clinical outcomes for patients with diabetes.

Who is the study for?
This trial is for adults aged 18-75 with Type 2 Diabetes who are on medication, can use a smartphone or computer with internet, and have an active patient web portal account at VUMC or BWH. They must be able to understand English or Spanish. Those on dialysis, pregnant, or in long-term care cannot join.
What is being tested?
The study tests 'My Diabetes Care', a patient portal intervention designed to improve diabetes management through technology. Participants will be randomly assigned to two groups: one using the MDC system and the other continuing usual care.
What are the potential side effects?
Since this trial involves a digital patient management tool rather than medication, traditional side effects are not expected. However, participants may experience issues related to usability of the app such as frustration or difficulty navigating the interface.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have Type 2 Diabetes.
Select...
I am between 18 and 75 years old.
Select...
I am currently on medication for diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently on dialysis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (t0), three-month follow-up (t1), six-month follow-up (t2), twelve-month follow-up (t3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (t0), three-month follow-up (t1), six-month follow-up (t2), twelve-month follow-up (t3) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Blood Glucose Control
Secondary study objectives
Change in Blood Pressure Control
Change in Body Mass Index (BMI)
Change in Diabetes Self-Care (Diabetes Medication Adherence)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: My Diabetes CareExperimental Treatment1 Intervention
Patients have access to an existing patient web portal (i.e., Epic's MyChart) embedded with My Diabetes Care.
Group II: Usual CareActive Control1 Intervention
Patients will have access to an existing patient web portal (i.e., Epic's MyChart) NOT embedded with My Diabetes Care (i.e., usual care)

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
888 Previous Clinical Trials
934,476 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,410 Previous Clinical Trials
4,324,433 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,765 Previous Clinical Trials
8,133,053 Total Patients Enrolled

Media Library

My Diabetes Care Clinical Trial Eligibility Overview. Trial Name: NCT05451914 — N/A
Type 2 Diabetes Research Study Groups: My Diabetes Care, Usual Care
Type 2 Diabetes Clinical Trial 2023: My Diabetes Care Highlights & Side Effects. Trial Name: NCT05451914 — N/A
My Diabetes Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05451914 — N/A
Type 2 Diabetes Patient Testimony for trial: Trial Name: NCT05451914 — N/A
~179 spots leftby Jun 2025